SION Earnings & Financial Statements
Sionna Therapeutics, Inc.
$4.08
-$0.01(-0.37%)
29
Overall
55
Value
9
Tech
23
Quality
Market Cap
$184.92M
Volume
368.12K
52W Range
$4.01 - $54.97
Target Price
$5.75
SION earnings and financial statements: Sionna Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SION Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating income | -$88.98M | -$70.56M | -$50.33M | -$41.37M |
| EBITDA | -$72.71M | -$64.02M | -$47.36M | -$40.52M |
| Net income | -$75.27M | -$61.69M | -$47.26M | -$40.24M |
| EPS (diluted) | $-1.88 | $-15.99 | $-16.11 | $-15.61 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $325.95M | $185.75M | $51.95M | $87.37M |
| Total liabilities | $19.12M | $19.10M | $17.79M | $8.25M |
| Shareholders’ equity | $306.83M | $166.66M | $34.16M | $79.12M |
| Cash and equivalents | $58.45M | $37.79M | $38.52M | $54.84M |
| Long-term debt | $7.41M | $8.68M | $9.75M | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$66.30M | -$52.79M | -$43.70M | -$36.07M |
| Capital expenditure | -$377.0K | - | - | - |
| Free cash flow | -$66.67M | -$52.81M | -$44.81M | -$37.94M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SION | $4.08 | -0.4% | 368.12K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Sionna Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW